| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | Oct 3, 2025 | Akero Therapeutics, Inc. | COO | Sell | 35.0 | -12,500 | -4.64% | ✓ | $597K |
| Sep 11, 2025 | Sep 12, 2025 | Akero Therapeutics, Inc. | COO | Sell | 51.3 | -586 | -0.23% | ✗ | $25.2K |
| Sep 2, 2025 | Sep 4, 2025 | Akero Therapeutics, Inc. | COO | Sell | 35.0 | -12,500 | -4.63% | ✓ | $576K |
| Aug 12, 2025 | Aug 13, 2025 | Akero Therapeutics, Inc. | COO | Sell | 35.0 | -12,500 | -4.63% | ✓ | $597.3K |
| Jun 18, 2025 | Jun 20, 2025 | Akero Therapeutics, Inc. | COO | Sell | 45.0 | -1,453 | -0.56% | ✗ | $79.7K |
| Jun 10, 2025 | Jun 12, 2025 | Akero Therapeutics, Inc. | COO | Sell | 45.0 | -2,493 | -0.96% | ✗ | $134.6K |
| Mar 12, 2025 | Mar 14, 2025 | Akero Therapeutics, Inc. | COO | Sell | 51.3 | -607 | -0.23% | ✗ | $27.2K |
| Mar 4, 2025 | Mar 5, 2025 | Akero Therapeutics, Inc. | COO | Sell | 15.0 | -50,000 | -16.07% | ✓ | $2.2M |
| Feb 3, 2025 | Feb 5, 2025 | Akero Therapeutics, Inc. | COO | Sell | 35.0 | -10,000 | -3.11% | ✓ | $538.1K |
| Jan 2, 2025 | Jan 6, 2025 | Akero Therapeutics, Inc. | COO | Sell | 35.0 | -10,000 | -3.47% | ✓ | $280.3K |
| Dec 10, 2024 | Dec 12, 2024 | Akero Therapeutics, Inc. | COO | Sell | 45.0 | -2,503 | -0.94% | ✗ | $77.1K |
| Dec 2, 2024 | Dec 4, 2024 | Akero Therapeutics, Inc. | COO | Sell | 35.0 | -10,000 | -3.62% | ✓ | $321.3K |
| Nov 1, 2024 | Nov 5, 2024 | Akero Therapeutics, Inc. | COO | Sell | 15.0 | -50,716 | -15.51% | ✓ | $1.6M |
| Oct 14, 2024 | Oct 16, 2024 | Akero Therapeutics, Inc. | COO | Sell | 20.0 | -40,000 | -12.26% | ✓ | $1.2M |
| Oct 1, 2024 | Oct 3, 2024 | Akero Therapeutics, Inc. | COO | Sell | 35.0 | -10,000 | -3.38% | ✓ | $281.8K |
| Sep 10, 2024 | Sep 13, 2024 | Akero Therapeutics, Inc. | COO | Sell | 51.3 | -568 | -0.19% | ✗ | $14.9K |
| Sep 3, 2024 | Sep 5, 2024 | Akero Therapeutics, Inc. | COO | Sell | 45.0 | -5,000 | -1.66% | ✓ | $133.6K |
| Aug 1, 2024 | Aug 2, 2024 | Akero Therapeutics, Inc. | COO | Sell | 45.0 | -5,000 | -1.63% | ✓ | $133.8K |
| Jun 28, 2024 | Jul 2, 2024 | Akero Therapeutics, Inc. | COO | Sell | 45.0 | -3,936 | -1.27% | ✓ | $117K |
| Jun 11, 2024 | Jun 13, 2024 | Akero Therapeutics, Inc. | COO | Sell | 45.0 | -2,516 | -0.80% | ✗ | $57K |
| Jun 3, 2024 | Jun 5, 2024 | Akero Therapeutics, Inc. | COO | Sell | 45.0 | -5,000 | -1.57% | ✓ | $96.4K |
| May 1, 2024 | May 2, 2024 | Akero Therapeutics, Inc. | COO | Sell | 45.0 | -5,000 | -1.55% | ✓ | $100.7K |
| Apr 1, 2024 | Apr 3, 2024 | Akero Therapeutics, Inc. | COO | Sell | 47.5 | -5,000 | -0.84% | ✓ | $121.9K |
| Mar 13, 2024 | Mar 15, 2024 | Akero Therapeutics, Inc. | COO | Sell | 51.3 | -651 | -0.20% | ✗ | $18.4K |
| Dec 27, 2023 | Dec 29, 2023 | Akero Therapeutics, Inc. | COO | Sell | 22.5 | -5,414 | -2.16% | ✗ | $129.9K |
| Dec 14, 2023 | Dec 18, 2023 | Akero Therapeutics, Inc. | COO | Sell | 51.3 | -543 | -0.22% | ✗ | $11.3K |
| Nov 17, 2023 | Nov 21, 2023 | Akero Therapeutics, Inc. | COO | Sell | 20.0 | -30,000 | -12.34% | ✗ | $440.3K |
| Oct 2, 2023 | Oct 4, 2023 | Akero Therapeutics, Inc. | COO | Sell | 53.8 | -490 | -0.20% | ✓ | $25K |
| Sep 13, 2023 | Sep 25, 2023 | Akero Therapeutics, Inc. | COO | Sell | 53.8 | -562 | -0.23% | ✓ | $28.3K |
| Jun 13, 2023 | Jun 15, 2023 | Akero Therapeutics, Inc. | COO | Sell | 53.8 | -538 | -0.22% | ✓ | $29.7K |
| Mar 10, 2023 | Mar 14, 2023 | Akero Therapeutics, Inc. | COO | Sell | 51.3 | -634 | -0.26% | ✗ | $27.6K |
| Jan 3, 2023 | Jan 5, 2023 | Akero Therapeutics, Inc. | COO | Sell | 35.0 | -8,777 | -3.46% | ✓ | $479.6K |
| Dec 27, 2022 | Dec 28, 2022 | Akero Therapeutics, Inc. | COO | Sell | 35.0 | -12,500 | -4.90% | ✓ | $619.6K |
| Oct 25, 2022 | Oct 27, 2022 | Akero Therapeutics, Inc. | COO | Sell | 30.0 | -12,500 | -5.30% | ✓ | $558.9K |
| Nov 3, 2021 | Nov 5, 2021 | Akero Therapeutics, Inc. | COO | Sell | 22.5 | -25,000 | -11.34% | ✓ | $607.1K |
| Sep 1, 2021 | Sep 3, 2021 | Akero Therapeutics, Inc. | COO | Sell | 30.0 | -12,500 | -5.36% | ✓ | $300.5K |
| Jun 1, 2021 | Jun 2, 2021 | Akero Therapeutics, Inc. | COO | Sell | 45.0 | -3,055 | -1.35% | ✓ | $80.2K |
| May 3, 2021 | May 4, 2021 | Akero Therapeutics, Inc. | COO | Sell | 45.0 | -3,055 | -1.33% | ✓ | $93.4K |
| Apr 1, 2021 | Apr 5, 2021 | Akero Therapeutics, Inc. | COO | Sell | 45.0 | -3,055 | -1.31% | ✓ | $87.8K |
| Mar 1, 2021 | Mar 2, 2021 | Akero Therapeutics, Inc. | COO | Sell | 45.0 | -3,055 | -1.29% | ✓ | $93.1K |
| Feb 1, 2021 | Feb 2, 2021 | Akero Therapeutics, Inc. | COO | Sell | 45.0 | -3,055 | -1.28% | ✓ | $89.3K |
| Jan 7, 2021 | Jan 11, 2021 | Akero Therapeutics, Inc. | COO | Sell | 35.0 | -10,000 | -4.01% | ✓ | $281.2K |
| Jan 4, 2021 | Jan 6, 2021 | Akero Therapeutics, Inc. | COO | Sell | 45.0 | -3,060 | -1.25% | ✓ | $77.4K |